The Optimal First-Line Therapy ofHelicobacter pyloriInfection in Year 2012

Evaluation of a Four-drug, Three-antibiotic, Nonbismuth-containing “Concomitant” Therapy as First-line Helicobacter pylori Eradication Regimen in Greece

(2012) Sotirios Georgopoulos et al.   HELICOBACTER

Randomised clinical trial: comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in naïve patients

(2011) H. G. Park et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Review article: rifabutin in the treatment of refractory Helicobacter pylori infection

(2011) J. P. Gisbert et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Treatment of Helicobacter pylori

(2011) Michael Selgrad et al.   CURRENT OPINION IN GASTROENTEROLOGY

Treatment of Helicobacter pylori Infection 2011

(2011) Anthony O’Connor et al.   HELICOBACTER

Is There a Benefit to Extending the Duration of Helicobacter pylori Sequential Therapy to 14 Days?

(2011) Ping I. Hsu et al.   HELICOBACTER

Modified Sequential Helicobacter pylori Therapy: Proton Pump Inhibitor and Amoxicillin for 14 Days with Clarithromycin and Metronidazole added as a Quadruple (Hybrid) Therapy for the Final 7 Days

(2011) Ping-I. Hsu et al.   HELICOBACTER

Levofloxacin Based Sequential and Triple Therapy Compared with Standart Plus Probiotic Combination for Helicobacter Pylori Eradication

(2011) Kamil Özdil et al.   HEPATO-GASTROENTEROLOGY

14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial

(2011) E Robert Greenberg et al.   LANCET

Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial

(2011) Peter Malfertheiner et al.   LANCET

Optimal therapy for Helicobacter pylori infections

(2011) Emiko Rimbara et al.   Nature Reviews Gastroenterology & Hepatology

Role of Omeprazole Dosage and Cytochrome P450 2C19 Genotype in Patients Receiving Omeprazole-Amoxicillin Dual Therapy forHelicobacter pyloriEradication

(2011) Jyh-Chin Yang et al.   PHARMACOTHERAPY

A new look at anti-Helicobacter pylori therapy

(2011) Seng-Kee Chuah   WORLD JOURNAL OF GASTROENTEROLOGY

Clinical trial: clarithromycin vs. levofloxacin in first-line triple and sequential regimens forHelicobacter pylorieradication

(2010) J. MOLINA-INFANTE et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Corrigendum

(2010)   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Efficacy and tolerability of first-line triple therapy with levofloxacin and amoxicillin plus esomeprazole or rabeprazole for the eradication of Helicobacter pylori infection and the effect of CYP2C19 genotype: A 1-week, randomized, open-label study in chinese adults

(2010) Xiaolin Pan et al.   CLINICAL THERAPEUTICS

Helicobacter pylori resistance to metronidazole and clarithromycin in Ireland

(2010) Anthony OʼConnor et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial

(2010) M. Romano et al.   GUT

Helicobacter pylori treatment in the era of increasing antibiotic resistance

(2010) D. Y. Graham et al.   GUT

The Influence of CYP2C19 Polymorphism on Eradication of Helicobacter pylori: A Prospective Randomized Study of Lansoprazole and Rabeprazole

(2010) Jeong Hoon Lee et al.   Gut and Liver

Treatment of Helicobacter pylori Infection 2010

(2010) Anthony O’Connor et al.   HELICOBACTER

Rabeprazole Can Overcome the Impact of CYP2C19 Polymorphism on Quadruple Therapy

(2010) Chao-Hung Kuo et al.   HELICOBACTER

Role of Probiotics in Pediatric Patients withHelicobacter pyloriInfection: A Comprehensive Review of the Literature

(2010) Elena Lionetti et al.   HELICOBACTER

Comparison of the once-daily levofloxacin-containing triple therapy with the twice-daily standard triple therapy for first-line Helicobacter pylori eradication: a prospective randomised study

(2010) L.-W. Chen et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Personalized treatment in the eradication therapy for Helicobacter pylori

(2010) Nakatani   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Changes in 12-Year First-Line Eradication Rate of Helicobacter pylori Based on Triple Therapy with Proton Pump Inhibitor, Amoxicillin and Clarithromycin

(2010) Makoto Sasaki et al.   JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION

Efficacy of one-week proton pump inhibitor triple therapy as first-line Helicobacter Pylori eradication regime in Asian patients: Is it still effective 10 years on?

(2010) Choon-Seng QUA et al.   Journal of Digestive Diseases

Systematic review and meta-analysis ofSaccharomyces boulardiiin adult patients

(2010) Lynne V McFarland   WORLD JOURNAL OF GASTROENTEROLOGY

Should quinolones come first in Helicobacter pylori therapy?

(2010) Marco Berning et al.   Therapeutic Advances in Gastroenterology

Ten-Day Sequential Therapy of Helicobacter pylori Infection in Thailand

(2009) Nathavut Sirimontaporn et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Sequential Therapy or Triple Therapy for Helicobacter pylori Infection: Systematic Review and Meta-Analysis of Randomized Controlled Trials in Adults and Children

(2009) Luigi Gatta et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Sequential and Concomitant Therapy With Four Drugs Is Equally Effective for Eradication of H pylori Infection

(2009) Deng–Chyang Wu et al.   Clinical Gastroenterology and Hepatology

Helicobacter pylori first-line treatment and rescue option containing levofloxacin in patients allergic to penicillin

(2009) J.P. Gisbert et al.   DIGESTIVE AND LIVER DISEASE

Meta-Analysis: Lactobacillus Containing Quadruple Therapy Versus Standard Triple First-Line Therapy for Helicobacter pylori Eradication

(2009) Jian Zou et al.   HELICOBACTER

Meta-analysis: Four-Drug, Three-Antibiotic, Non-bismuth-Containing “Concomitant Therapy” Versus Triple Therapy forHelicobacter pyloriEradication

(2009) Abdallah Said Essa et al.   HELICOBACTER

Efficacy of levofloxacin-based rescue therapy for Helicobacter pylori infection after standard triple therapy: a randomized controlled trial

(2009) C.-H. Kuo et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Second Asia-Pacific Consensus Guidelines forHelicobacter pyloriinfection

(2009) K Ming Fock et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Resistance to metronidazole, clarithromycin and levofloxacin ofHelicobacter pyloribefore and after clarithromycin-based therapy in Taiwan

(2009) Wei-Lun Chang et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Therapy for Helicobacter pylori Infection Can be Improved

(2008) David Y Graham et al.   DRUGS

Effect of the CYP2C19 polymorphism on the eradication rate ofHelicobacter pyloriinfection by 7-day triple therapy with regular proton pump inhibitor dosage

(2008) Jung Mook Kang et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

The Eradication of Helicobacter pylori is Affected by Body Mass Index (BMI)

(2008) Mohamed Abdullahi et al.   OBESITY SURGERY